Position in AZN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$369,602,942
-$26,808,666 QoQ
Shares Held
1,949,177
-3.0% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
2.62%
of 13F equity value
Holder Rank
#71
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital International, Inc./CA/ holds $998,315,428 across 11 Drug Manufacturers - General names. AZN ranks #1 (37.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
1,949,177 | $369,602,942 | |
| 2 | LLY |
ELI LILLY & Co
|
198,681 | $238,303,971 | |
| 3 | ABBV |
AbbVie Inc.
|
435,569 | $109,606,583 | |
| 4 | AMGN |
Amgen Inc
|
299,765 | $108,550,901 | |
| 5 | MRK |
Merck & Co., Inc.
|
454,397 | $58,390,014 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
363,947 | $45,981,063 | |
| 7 | JNJ |
Johnson & Johnson
|
178,793 | $45,408,058 | |
| 8 | PFE |
Pfizer Inc
|
376,556 | $9,067,468 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $369,602,942 | 1,949,177 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $396,411,608 | 2,009,997 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||